What is the recommended initial dose of epinephrine (Epi) for anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Initial Dose of Epinephrine for Anaphylaxis

The recommended initial dose of epinephrine for anaphylaxis is 0.2 to 0.5 mg (1:1000 concentration) intramuscularly into the anterolateral thigh, to be repeated every 5 to 15 minutes as needed. 1

Adult Dosing

  • For adults and children weighing ≥30 kg (66 lbs):
    • 0.3 to 0.5 mg (0.3 to 0.5 mL of 1:1000 concentration) 1, 2
    • Maximum initial dose: 0.5 mg 1
    • Administered intramuscularly into the anterolateral thigh
    • May repeat every 5-15 minutes as needed based on clinical response 1

Pediatric Dosing

  • For children weighing <30 kg (66 lbs):
    • 0.01 mg/kg (0.01 mL/kg of 1:1000 concentration) 1, 2
    • Maximum dose: 0.3 mg in prepubertal children 1
    • Administered intramuscularly into the anterolateral thigh
    • May repeat every 5-15 minutes as needed based on clinical response

Autoinjector Dosing Recommendations

When using epinephrine autoinjectors in community settings:

  • 0.15 mg autoinjector: For children weighing 7.5-25 kg (16.5-55 lbs) 1
  • 0.3 mg autoinjector: For individuals weighing ≥25 kg (55 lbs) 1
  • 0.5 mg autoinjector: Consider for individuals weighing ≥45 kg based on shared decision-making 3

Route of Administration

  • Preferred route: Intramuscular injection into the anterolateral thigh (vastus lateralis) 1

    • Achieves peak plasma concentrations promptly 1
    • More effective and safer than subcutaneous administration
  • Alternative route (only when IV access is already established and in anaphylactic shock):

    • IV dose: 0.05 to 0.1 mg (5-10% of cardiac arrest dose) 1
    • Should only be considered in profound hypotension unresponsive to IM epinephrine and fluid resuscitation 1

Important Clinical Considerations

  • Epinephrine is the cornerstone of anaphylaxis treatment and should be administered promptly 1

  • Delayed administration is associated with poor outcomes, including fatality 1

  • Antihistamines and bronchodilators are adjunctive treatments and should never replace epinephrine 1

  • Common pitfalls:

    • Delayed administration due to uncertainty about diagnosis
    • Inappropriate route (subcutaneous instead of intramuscular)
    • Confusion between anaphylaxis dosing (1:1000) and cardiac arrest dosing (1:10,000) 4
    • Underdosing in larger patients when using standard autoinjectors 3
  • For patients with refractory symptoms, consider:

    • Repeated IM doses of epinephrine every 5-15 minutes 1
    • IV fluid resuscitation with normal saline 1
    • Close hemodynamic monitoring 1

Epinephrine remains the most effective medication for anaphylaxis with its life-saving pharmacologic effects on multiple organ systems, preventing and relieving both upper and lower airway obstruction and shock 5. The intramuscular route in the anterolateral thigh provides the optimal therapeutic window with rapid onset of action and reduced risk of adverse effects compared to intravenous administration.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

CSACI position statement: transition recommendations on existing epinephrine autoinjectors.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2021

Research

Epinephrine (adrenaline) in anaphylaxis.

Chemical immunology and allergy, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.